Literature DB >> 1849765

Characterization and actions of human umbilical endothelium derived relaxing factor.

G Chaudhuri1, G M Buga, M E Gold, K S Wood, L J Ignarro.   

Abstract

1. A bioassay cascade superfusion technique was utilized to study the properties of endothelium derived relaxing factor (EDRF) from human umbilical vein (HUV) and compare its actions on umbilical, chorionic plate and bovine pulmonary arterial strips. 2. Histamine (1 microM), bradykinin (1 microM) and A-23187 (0.3 microM, 1 microM) but not acetylcholine (1 microM) released EDRF. 3. The non-innervated human foetoplacental vessels, i.e., umbilical and chorionic plate arteries, do relax to EDRF by a guanosine 3':5'-cyclic monophosphate (cyclic GMP)-mediated mechanism. 4. The sensitivity of the human umbilical arterial strips to EDRF was less than that of the chronic plate arterial strips. Bovine pulmonary arterial strips were the most sensitive to the relaxant actions of human umbilical EDRF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849765      PMCID: PMC1918038          DOI: 10.1111/j.1476-5381.1991.tb12174.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Action of adrenaline, acetylcholine and other substances on nerve-free vessels (human placenta).

Authors:  U S V Euler
Journal:  J Physiol       Date:  1938-07-14       Impact factor: 5.182

2.  Endothelium-derived nitric oxide relaxes nonvascular smooth muscle.

Authors:  G M Buga; M E Gold; K S Wood; G Chaudhuri; L J Ignarro
Journal:  Eur J Pharmacol       Date:  1989-02-14       Impact factor: 4.432

3.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

Authors:  L J Ignarro; G M Buga; K S Wood; R E Byrns; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells.

Authors:  R J Gryglewski; S Moncada; R M Palmer
Journal:  Br J Pharmacol       Date:  1986-04       Impact factor: 8.739

5.  EDRF generation and release from perfused bovine pulmonary artery and vein.

Authors:  L J Ignarro; G M Buga; G Chaudhuri
Journal:  Eur J Pharmacol       Date:  1988-04-27       Impact factor: 4.432

6.  Formation and action of prostaglandin endoperoxides in the isolated human umbilical artery.

Authors:  T Tuvemo; K Strandberg; M Hamberg; B Samuelsson
Journal:  Acta Physiol Scand       Date:  1976-02

7.  In vitro perfusion studies on human umbilical arteries. II. Effects of prostacyclin and a thromboxane A2 mimetic.

Authors:  K Bjøro; S Stray-Pedersen
Journal:  Acta Obstet Gynecol Scand       Date:  1986       Impact factor: 3.636

8.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

9.  Release of endothelium-derived relaxing factor from human umbilical vessels.

Authors:  J Van de Voorde; H Vanderstichele; I Leusen
Journal:  Circ Res       Date:  1987-04       Impact factor: 17.367

10.  Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms.

Authors:  L J Ignarro; J B Adams; P M Horwitz; K S Wood
Journal:  J Biol Chem       Date:  1986-04-15       Impact factor: 5.157

View more
  10 in total

1.  Contractile actions of thrombin receptor-derived polypeptides in human umbilical and placental vasculature: evidence for distinct receptor systems.

Authors:  J Tay-Uyboco; M C Poon; S Ahmad; M D Hollenberg
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

2.  Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and pre-eclamptic pregnancies.

Authors:  R A Rutherford; A McCarthy; M H Sullivan; M G Elder; J M Polak; J Wharton
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

3.  Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants.

Authors:  X Li; M Shams; J Zhu; A Khalig; M Wilkes; M Whittle; N Barnes; A Ahmed
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

4.  Pharmacological characterization of muscarinic receptor subtypes mediating vasoconstriction of human umbilical vein.

Authors:  Virginia Andrea Pujol Lereis; Francisco Javier Hita; Mauro Darío Gobbi; Marcela Gomez Verdi; María Cecilia Rodriguez; Rodolfo Pedro Rothlin
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

5.  Nitric oxide and sodium nitroprusside-induced relaxation of the human umbilical artery.

Authors:  F Lovren; C Triggle
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

6.  Localization of neuropeptide Y and atrial natriuretic peptide in the endothelial cells of human umbilical blood vessels.

Authors:  W Q Cai; P Bodin; A Sexton; A Loesch; G Burnstock
Journal:  Cell Tissue Res       Date:  1993-04       Impact factor: 5.249

7.  The effect of endothelins on nitric oxide and prostacyclin production from human umbilical vein, porcine aorta and bovine carotid artery endothelial cells in culture.

Authors:  D G White; J W Mundin; M J Sumner; I S Watts
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

8.  Immunological detection of nitric oxide synthase(s) in human tissues using heterologous antibodies suggesting different isoforms.

Authors:  D R Springall; V Riveros-Moreno; L Buttery; A Suburo; A E Bishop; M Merrett; S Moncada; J M Polak
Journal:  Histochemistry       Date:  1992-11

9.  Impaired cyclic nucleotide-mediated vasorelaxation may contribute to closure of the human umbilical artery after birth.

Authors:  S Renowden; D H Edwards; T M Griffith
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

10.  Agonist-induced desensitization of histamine H1 receptor-mediated inositol phospholipid hydrolysis in human umbilical vein endothelial cells.

Authors:  G McCreath; I P Hall; S J Hill
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.